SEC Form 4 · accession 0001179110-18-001377

ABBOTT LABORATORIES · ABT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Executive Vice President

Period of report

Jan 30, 2018

Accepted (ET)

Feb 1, 2018 · 5:49 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000001800

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common shares without par value	Jan 30, 2018	S	945	$62.825	D	152,343	D
Common shares without par value	Jan 30, 2018	S	3,506	$62.83	D	148,837	D
Common shares without par value	Jan 30, 2018	S	662	$62.835	D	148,175	D
Common shares without par value	Jan 30, 2018	S	3,502	$62.84	D	144,673	D
Common shares without par value	Jan 30, 2018	S	1,198	$62.845	D	143,475	D
Common shares without par value	Jan 30, 2018	S	1,400	$62.85	D	142,075	D
Common shares without par value	Jan 30, 2018	S	600	$62.855	D	141,475	D
Common shares without par value	Jan 30, 2018	S	700	$62.86	D	140,775	D
Common shares without par value	Jan 30, 2018	S	600	$62.87	D	140,175	D
Common shares without par value	Jan 30, 2018	S	200	$62.89	D	139,975	D
Common shares without par value^F1	holding	—	—		—	1,587	I	Profit Sharing Trust
Common shares without par value^F2	holding	—	—		—	53	I	By Spouse

No Table II lines on this filing.

F1Balance in the Abbott Laboratories Stock Retirement Trust as of January 31, 2018.
F2The reporting person disclaims beneficial ownership of all securities held by his spouse.

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).Form 4 of 4.